Zobrazeno 1 - 10
of 231
pro vyhledávání: '"Hideyuki Nakagawa"'
Publikováno v:
JA Clinical Reports, Vol 8, Iss 1, Pp 1-4 (2022)
Abstract Background Transcranial motor-evoked potential (Tc-MEP) monitoring is usually performed during surgeries involving a risk of damaging brain motor areas. However, it involves a risk of bite injuries. We report a case of severe tongue lacerati
Externí odkaz:
https://doaj.org/article/5e5b6b28023b4add9c66d8c02b7c7737
Autor:
Saori Takata, Kei Morikawa, Hisashi Tanaka, Hidetoshi Itani, Masashi Ishihara, Kazuya Horiuchi, Yasuhiro Kato, Shinnosuke Ikemura, Hideyuki Nakagawa, Yoshiro Nakahara, Yoshitaka Seki, Akihiro Bessho, Nobumasa Takahashi, Kentaro Hayashi, Takeo Endo, Kiyoshi Takeyama, Toshiya Maekura, Nagio Takigawa, Akikazu Kawase, Makoto Endoh, Kenji Nemoto, Kazuma Kishi, Kenzo Soejima, Yusuke Okuma, Kenichi Yoshimura, Daisuke Saigusa, Yae Kanai, Koji Ueda, Akira Togashi, Noriyuki Matsutani, Nobuhiko Seki
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: The exosome-focused translational research for afatinib (EXTRA) study is the first trial to identify novel predictive biomarkers for longer treatment efficacy of afatinib in patients with epidermal growth factor receptor ( EGFR ) mutation
Externí odkaz:
https://doaj.org/article/f62d5588d7244b819241b0e2adeb0dc1
Publikováno v:
JA Clinical Reports, Vol 8, Iss 1, Pp 1-5 (2022)
Abstract Background Establishing one-lung ventilation (OLV) in patients with tracheal bronchus (TB) may be challenging due to its unusual bronchial anatomy. We present a case of difficult OLV in a patient with right TB and steeply angled bifurcation
Externí odkaz:
https://doaj.org/article/9713b0f7290f480eb4ac32bdfb7c6d4d
Autor:
Takeshi Fujita, Hideyuki Nakagawa, Takashi Yokota, Jun Umetani, Daiki Nagawa, Masamichi Nakata, Ikuyo Narita-Kinjo, Reiichi Murakami, Michiko Shimada, Norio Nakamura, Hirofumi Tomita
Publikováno v:
Case Reports in Nephrology and Dialysis, Vol 11, Iss 2, Pp 227-232 (2021)
Nintedanib is a unique tyrosine kinase inhibitor used to suppress fibrosis in patients with idiopathic pulmonary fibrosis (IPF). Nintedanib has been shown to suppress multiple processes of fibrosis, thereby reducing the rate of lung function decline
Externí odkaz:
https://doaj.org/article/1b1b74cdc7c340ea831c2cb159b62d7e
Autor:
Rie Inoue, Daisuke Nishizawa, Junko Hasegawa, Kyoko Nakayama, Ken‐ichi Fukuda, Tatsuya Ichinohe, Tsutomu Mieda, Miki Tsujita, Hideyuki Nakagawa, Akira Kitamura, Hiroyuki Sumikura, Kazutaka Ikeda, Masakazu Hayashida
Publikováno v:
Neuropsychopharmacology Reports, Vol 41, Iss 1, Pp 82-90 (2021)
Abstract Background Opioids are widely used as effective analgesics, but opioid sensitivity varies widely among individuals. The underlying genetic and nongenetic factors are not fully understood. Based on the results of our previous genome‐wide as
Externí odkaz:
https://doaj.org/article/87bbe8338dbf402a824e897ea0ff720b
Autor:
Daisuke Nishizawa, Tsutomu Mieda, Miki Tsujita, Hideyuki Nakagawa, Shigeki Yamaguchi, Shinya Kasai, Junko Hasegawa, Kyoko Nakayama, Yuko Ebata, Akira Kitamura, Hirotomo Shimizu, Tadayuki Takashima, Masakazu Hayashida, Kazutaka Ikeda
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 9, p 8421 (2023)
Sensitivity to opioids varies widely among individuals. To identify potential candidate single-nucleotide polymorphisms (SNPs) that may significantly contribute to individual differences in the minimum effective concentration (MEC) of an opioid, fent
Externí odkaz:
https://doaj.org/article/b98a165be0a74d59806c99af4d120be9
Autor:
Yusuke Okuma, Kei Morikawa, Hisashi Tanaka, Takuma Yokoyama, Hidetoshi Itani, Kazuya Horiuchi, Hideyuki Nakagawa, Nobumasa Takahashi, Akihiro Bessho, Kenzo Soejima, Kazuma Kishi, Akira Togashi, Yae Kanai, Koji Ueda, Katsuhisa Horimoto, Noriyuki Matsutani, Nobuhiko Seki
Publikováno v:
Thoracic Cancer, Vol 10, Iss 2, Pp 395-400 (2019)
Patients with EGFR‐mutated non‐small cell lung cancer (NSCLC) exhibit resistance to EGFR‐tyrosine kinase inhibitors (TKIs) within 9–14 months of therapy. Recently, EGFR‐mutated NSCLC has demonstrated the potential for heterogeneity; therefo
Externí odkaz:
https://doaj.org/article/a40c33dc9f54408a9086bcfe804537d4
Publikováno v:
Journal of Medical Case Reports, Vol 13, Iss 1, Pp 1-6 (2019)
Abstract Background Warthin tumor is a common, benign, painless salivary gland neoplasm. Rarely, Warthin tumors show large areas of squamous metaplasia; such Warthin tumors are called metaplastic or infarcted Warthin tumors because they are occasiona
Externí odkaz:
https://doaj.org/article/cfb2868fc06444719028a0d39f91b288
Autor:
Shigeru Tanzawa, Sunao Ushijima, Kazuhiko Shibata, Takuo Shibayama, Akihiro Bessho, Kyoichi Kaira, Toshihiro Misumi, Kenshiro Shiraishi, Noriyuki Matsutani, Hisashi Tanaka, Megumi Inaba, Terunobu Haruyama, Junya Nakamura, Takayuki Kishikawa, Masanao Nakashima, Keiichi Iwasa, Keiichi Fujiwara, Tadashi Kohyama, Shoichi Kuyama, Naoki Miyazawa, Tomomi Nakamura, Hiroshi Miyawaki, Hiroo Ishida, Naohiro Oda, Nobuhisa Ishikawa, Ryotaro Morinaga, Kei Kusaka, Nobukazu Fujimoto, Toshihide Yokoyama, Kenichi Gemba, Takeshi Tsuda, Hideyuki Nakagawa, Hirotaka Ono, Tetsuo Shimizu, Morio Nakamura, Sojiro Kusumoto, Ryuji Hayashi, Hiroki Shirasaki, Nobuaki Ochi, Keisuke Aoe, Nobuhiro Kanaji, Kosuke Kashiwabara, Hiroshi Inoue, Nobuhiko Seki
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Based on the results of the PACIFIC study, chemoradiotherapy followed by 1-year consolidation therapy with durvalumab was established as the standard of care for unresectable, locally advanced non-small-cell lung cancer (LA-NSCLC). Howeve
Externí odkaz:
https://doaj.org/article/96f6f9e07bb84541842c0f47686bf218
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Abstract Purinergic P2Y 2 receptors, G-protein coupled receptors that primarily couple with Gαq/11-proteins, are activated equipotently by adenosine-5′-triphosphate (ATP) and uridine-5′-triphosphate. Evidence suggests that P2Y 2 agonists make po
Externí odkaz:
https://doaj.org/article/7318d80836ef4964a22fb41a3fcb7561